...
首页> 外文期刊>Clinical Medicine and Diagnostics >Laminin and Chromogranin A as Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma
【24h】

Laminin and Chromogranin A as Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma

机译:层粘连蛋白和嗜铬粒蛋白A作为肝细胞肝癌肝纤维化的血清标志物

获取原文
           

摘要

Cirrhosis of the liver is the most important risk factor for hepatocellular carcinoma (HCC), which represents the leading cause of death in these patients. The most useful serum marker of the tumor, alpha-fetoprotein (AFP), has a highly variable sensitivity and specificity in the reported studies. Laminin (Ln) is a glycoprotein which has an important role in the mechanism of fibrogenesis and is, thus, related to hepatic fibrosis in addition to presenting increased levels in several types of neoplasias. Elevated Chromogranin-A(CgA) in patients with cirrhosis and superimposed HCC suggesting that raising CgA levels, likely due to a neuroendocrine component of the tumor, might be a useful prognostic marker for HCC in cirrhotic patients. Aim of the work: The objective of the present study is to determine the relationship between laminin and chromogranin- A in plasma of patients with hepatocellular carcinoma in order to determine whether laminin and chromogranin- A may serve as markers for liver fibrosis and whether these parameters could be correlate with liver functions of these patients Subjects and methods: This study was conducted on 50 Egyptian subjects and classified into two groups: Thirty patients of hepatocellular carcinoma (HCC) with previous history of hepatitis C group(G II) (n = 30), in addition to twenty age and sex matched healthy individuals as a control group(GI). HCC was diagnosed histologically or by imaging. They were recruited from the outpatient clinic of Internal Medicine Department of Al-Zaharaa University Hospital, Cairo, Egypt. Liver function tests (AST, ALT, GGT, total bilirubin and albumin) by colorimetric assay, Plasma Laminin and chromogranin-A (by ELISA) and alpha fetoprotein (by immunometric assay) were estimated. Results: laminin and CgA levels were significantly higher in group II (HCC patients) when compared to group I (control subjects) (p<0.0001). Statistically significant positive correlation between CgA versus Ln at HCC group (p< 0.0001). Statistically significant positive correlation between CgA versus GGT (p=0.001) and Ln versus GGT at HCC group (p< 0.0001). CgA level shows best cut off 106 (ng/ml) and Ln level shows best cut off 1065 (ng/ml) and CgA and Ln levels shows %100 sensitivity and %100 specificity in HCC group, which proof that both markers are considered high validity tests in prediction of HCC and hepatic cirrhosis. Conclusions: Laminin and CgA represent useful diagnostic as well as prognostic biomarkers for liver cirrhosis and HCC.
机译:肝硬化是肝细胞癌(HCC)的最重要危险因素,代表这些患者的主要死亡原因。肿瘤中最有用的血清标志物甲胎蛋白(AFP)在已报道的研究中具有高度可变的敏感性和特异性。层粘连蛋白(Ln)是一种糖蛋白,在纤维生成的机制中起着重要的作用,因此除了在几种类型的肿瘤中水平升高外,还与肝纤维化有关。肝硬化和HCC重叠患者中嗜铬粒蛋白A(CgA)升高提示可能由于肿瘤的神经内分泌成分而升高CgA水平可能是肝硬化患者HCC的有用预后标志物。工作的目的:本研究的目的是确定肝细胞癌患者血浆中层粘连蛋白和嗜铬粒蛋白-A之间的关系,以便确定层粘连蛋白和嗜铬粒蛋白-A是否可作为肝纤维化的标志物以及这些参数可能与这些患者的肝功能相关。研究对象和方法:这项研究针对50名埃及受试者进行,分为两组:30例曾有丙型肝炎病史(G II)的肝细胞癌(HCC)(n = 30 ),另外还有20个年龄和性别相匹配的健康个体作为对照组(GI)。 HCC是通过组织学或影像学诊断的。他们是从埃及开罗Al-Zaharaa大学医院内科门诊招募的。通过比色测定,血浆层粘连蛋白和嗜铬粒蛋白-A(通过ELISA)和甲胎蛋白(通过免疫测定)评估肝功能测试(AST,ALT,GGT,总胆红素和白蛋白)。结果:与I组(对照组)相比,II组(HCC患者)的层粘连蛋白和CgA水平显着更高(p <0.0001)。在HCC组中,CgA与Ln之间的统计显着正相关(p <0.0001)。在HCC组,CgA与GGT(p = 0.001)和Ln与GGT之间的统计学显着正相关(p <0.0001)。 CgA水平显示最佳截止值106(ng / ml),Ln水平显示最佳截止值1065(ng / ml),CgA和Ln水平显示HCC组的%100敏感性和%100特异性,这证明这两个标记均被认为是高标记肝癌和肝硬化预测中的效度测试。结论:层粘连蛋白和CgA代表肝硬化和HCC的有用诊断和预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号